DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Ferretti G, Bria E, Giannarelli D et al.
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.
Br J Cancer 2006;
94: 1789-1796
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.